E2F4 and neoplasm: In our experimental system, E2F4 knock-down did not translate into a reduction in the frequency of organoid-initiating cells (in vitro) or the frequency of tumor-initiating cells (in vivo) as evaluated by an extreme limiting dilution assay (ELDA).